Arkolith/Insider Trading/TECH/Form 4

Kelderman Kim

Chief Executive Officer, DirectorBIO-TECHNE Corp (TECH) · full profile →Form 4 · filed May 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)27K$47.60$1.3M90K
May 5, 2026Tax withholding(F)24K$56.68$1.4M66K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)27K—$035K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000914190-26-000088) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML